Citations

Clear

171 citation(s) found for "Moss, M".

Decreasing PICU Catheter-Associated Bloodstream Infections: NACHRI's Quality Transformation Efforts
Miller, Marlene R. , Griswold, Michael , Harris, J. Mitchell, Yenokyan, Gayane , Moss, Michele , Rice, Tom B. , Ridling, Debra , Campbell, Deborah, Margolis, Peter A. , Muething, Stephen E., Brilli, Richard J., Huskins, W. Charles

Mayo Clinic

Pediatrics | January 11, 2010 | Volume: 125 | Issue: 2 | Pages: 206-213

10.1542/peds.2009-1382 | PMID 20064860 Get It

OBJECTIVE: Despite the magnitude of the problem of catheter-associated bloodstream infections (CA-BSIs) in children, relatively little research has been performed to identify effective strategies to reduce these complications. In this study, we aimed to develop and evaluate effective catheter-care practices to reduce pediatric CA-BSIs. STUDY DESIGN AND METHODS: Our study was a multi-institutional, interrupted time-series design with historical control data and was conducted in 29 PICUs across the United States. Two central venous catheter–care practice bundles comprised our intervention: the insertion bundle of pediatric-tailored care elements derived from adult efforts and the maintenance bundle derived from the Centers for Disease Control and Prevention recommendations and expert pediatric clinician consensus. The bundles were deployed with quality-improvement teaching and methods to support their adoption by teams at the participating PICUs. The main outcome measures were the rate of CA-BSIs from January 2004 to September 2007 and compliance with each element of the insertion and maintenance bundles from October 2006 to September 2007. RESULTS: Average CA-BSI rates were reduced by 43% across 29 PICUs (5.4 vs 3.1 CA-BSIs per 1000 central-line-days; P < .0001). By September 2007, insertion-bundle compliance was 84% and maintenance-bundle compliance was 82%. Hierarchical regression modeling showed that the only significant predictor of an observed decrease in infection rates was the collective use of the insertion and maintenance bundles, as demonstrated by the relative rate (RR) and confidence intervals (CIs) (RR: 0.57 [95% CI: 0.45–0.74]; P < .0001). We used comparable modeling to assess the relative importance of the insertion versus maintenance bundles; the results showed that the only significant predictor of an infection-rate decrease was maintenance-bundle compliance (RR: 0.41 [95% CI: 0.20–0.85]; P = .017). CONCLUSIONS: In contrast with adult ICU care, maximizing insertion-bundle compliance alone cannot help PICUs to eliminate CA-BSIs. The main drivers for additional reductions in pediatric CA-BSI rates are issues that surround daily maintenance care for central lines, as defined in our maintenance bundle. Additional research is needed to define the optimal maintenance bundle that will facilitate elimination of CA-BSIs for children.
Expression Patterns of Cardiac Myofilament Proteins
Theis, Jeanne L. , Bos, J. Martijn , Theis, Jason D. , Miller, Dylan V. , Schaff, Hartzell V. , Ommen, Steve R. , Moss, Richard L. , Ackerman, Michael J. , Dearani, Joseph A. , Gersh, Bernard J. , Bos, Johan M , Schaff, Hartzell , Theis, Jeanne L

Mayo Clinic

Circulation: Heart Failure | May 14, 2009 | Volume: 2 | Issue: 4 | Pages: 325-333

10.1161/circheartfailure.108.789735 | PMID 19808356 Get It

Background— Mutations in myofilament proteins, most commonly MYBPC3 -encoded myosin-binding protein C and MYH7 -encoded β-myosin heavy chain, can cause hypertrophic cardiomyopathy (HCM). Despite significant advances in structure-function relationships pertaining to the cardiac sarcomere, there is limited knowledge of how a mutation leads to clinical HCM. We, therefore, set out to study expression and localization of myofilament proteins in left ventricular tissue of patients with HCM. Methods and Results— Frozen surgical myectomy specimens from 47 patients with HCM were examined and genotyped for mutations involving 8 myofilament-encoding genes. Myofilament protein levels were quantified by Western blotting with localization graded from immunohistochemical staining of tissue sections. Overall, 25 of 47 (53%) patients had myofilament-HCM, including 12 with MYBPC3-HCM and 9 with MYH7-HCM. As compared with healthy heart tissue, levels of myofilament proteins were increased in patients manifesting a mutation in either gene. Patients with a frameshift mutation predicted to truncate MYBPC3 exhibited marked disturbances in protein localization as compared with missense mutations in either MYBPC3 or MYH7 . Conclusions— In this first expression study in human HCM tissue, increased myofilament protein levels in patients with either MYBPC3 - or MYH7- mediated HCM suggest a poison peptide mechanism. Specifically, the mechanism of dysfunction may vary according to the genetic subgroup suggested by a distinctly abnormal distribution of myofilament proteins in patients manifesting a truncation mutation in MYBPC3 .
α-1-Syntrophin Mutation and the Long-QT Syndrome
Wu, Geru, Ai, Tomohiko , Mohapatra, Bhagyalaxmi , Xi, Yutao , Abbasi, Shahrzad, Purevjav, Enkhsaikhan , Samani, Kaveh, Ackerman, Michael J. , Qi, Ming , Moss, Arthur J. , Towbin, Jeffrey A. , Vatta, Matteo , Kim, Jeffrey J. , Li, Zhaohui , Shimizu, Wataru , Cheng, Jie

Mayo Clinic

Circulation: Arrhythmia and Electrophysiology | May 28, 2008 | Volume: 1 | Issue: 3 | Pages: 193-201

10.1161/circep.108.769224 | PMID 19684871 Get It

Background— Long-QT syndrome (LQTS) is an inherited disorder associated with sudden cardiac death. The cytoskeletal protein syntrophin-α 1 (SNTA1) is known to interact with the cardiac sodium channel (hNa v 1.5), and we hypothesized that SNTA1 mutations might cause phenotypic LQTS in patients with genotypically normal hNa v 1.5 by secondarily disturbing sodium channel function. Methods and Results— Mutational analysis of SNTA1 was performed on 39 LQTS patients (QTc≥480 ms) with previously negative genetic screening for the known LQTS-causing genes. We identified a novel A257G- SNTA1 missense mutation, which affects a highly conserved residue, in 3 unrelated LQTS probands but not in 400 ethnic-matched control alleles. Only 1 of these probands had a preexisting family history of LQTS and sudden death with an additional intronic variant in KCNQ1. Electrophysiological analysis was performed using HEK-293 cells stably expressing hNa v 1.5 and transiently transfected with either wild-type or mutant SNTA1 and, in neonatal rat cardiomyocytes, transiently transfected with either wild-type or mutant SNTA1. In both HEK-293 cells and neonatal rat cardiomyocytes, increased peak sodium currents were noted along with a 10-mV negative shift of the onset and peak of currents of the current-voltage relationships. In addition, A257G-SNTA1 shifted the steady-state activation ( V h ) leftward by 9.4 mV, whereas the voltage-dependent inactivation kinetics and the late sodium currents were similar to wild-type SNTA1. Conclusion— SNTA1 is a new susceptibility gene for LQTS. A257G- SNTA1 can cause gain-of-function of Na v 1.5 similar to the LQT3.
Long-QT Syndrome After Age 40
Moss, Arthur J. , Polonsky, Slava, Peterson, Derick R. , McNitt, Scott , Zaręba, Wojciech , Andrews, Mark, Ackerman, Michael J. , Benhorin, Jesaia, Kaufman, Elizabeth S. , Locati, Emanuela H. , Napolitano, Carlo , Qi, Ming , Schwartz, Peter J. , Towbin, Jeffrey A. , Vincent, G. Michael, Goldenberg, Ilan , Bradley, James A. , Robinson, Jennifer L. , Priori, Silvia G. , Schwartz, Peter J. , Zhang, Li , Zareba, Wojciech

Mayo Clinic

Circulation | April 21, 2008 | Volume: 117 | Issue: 17 | Pages: 2192-2201

10.1161/circulationaha.107.729368 | PMID 18427134 Get It

Background— Previous studies that assessed the risk of life-threatening cardiac events in patients with congenital long-QT syndrome (LQTS) have focused mainly on the first 4 decades of life, whereas the clinical course of this inherited cardiac disorder in the older population has not been studied. Methods and Results— The risk of aborted cardiac arrest or death from age 41 though 75 years was assessed in 2759 subjects from the International LQTS Registry, categorized into electrocardiographically affected (corrected QT interval [QTc] ≥470 ms), borderline (QTc 440 to 469 ms), and unaffected (QTc <440 ms) subgroups. The affected versus unaffected adjusted hazard ratio for aborted cardiac arrest or death was 2.65 ( P <0.001) in the age range of 41 to 60 years and 1.23 ( P =0.31) in the age range of 61 to 75 years. The clinical course of study subjects displayed gender differences: Affected LQTS women experienced a significantly higher cumulative event rate (26%) than borderline (16%) and unaffected (12%) women ( P =0.001), whereas event rates were similar among the 3 respective subgroups of men (29%, 26%, and 27%; P =0.16). Recent syncope (<2 years in the past) was the predominant risk factor in affected subjects (hazard ratio 9.92, P <0.001), and the LQT3 genotype was identified as the most powerful predictor of outcome in a subset of 871 study subjects who were genetically tested for a known LQTS mutation (hazard ratio 4.76, P =0.02). Conclusions— LQTS subjects maintain a high risk for life-threatening cardiac events after age 40 years. The phenotypic expression of affected subjects is influenced by age-specific factors related to gender, clinical history, and the LQTS genotype.
Risk Factors for Aborted Cardiac Arrest and Sudden Cardiac Death in Children With the Congenital Long-QT Syndrome
Moss, Arthur J. , Peterson, Derick R. , McNitt, Scott , Zaręba, Wojciech , Andrews, Mark, Locati, Emanuela H. , Ackerman, Michael J. , Benhorin, Jesaia, Kaufman, Elizabeth S. , Napolitano, Carlo , Qi, Ming , Schwartz, Peter J. , Towbin, Jeffrey A. , Vincent, G. Michael, Goldenberg, Ilan , Robinson, Jennifer L. , Priori, Silvia G. , Schwartz, Peter J. , Zhang, Li , Zareba, Wojciech

Mayo Clinic

Circulation | April 21, 2008 | Volume: 117 | Issue: 17 | Pages: 2184-2191

10.1161/circulationaha.107.701243 | PMID 18427136 Get It

Background— The congenital long-QT syndrome (LQTS) is an important cause of sudden cardiac death in children without structural heart disease. However, specific risk factors for life-threatening cardiac events in children with this genetic disorder have not been identified. Methods and Results— Cox proportional-hazards regression modeling was used to identify risk factors for aborted cardiac arrest or sudden cardiac death in 3015 LQTS children from the International LQTS Registry who were followed up from 1 through 12 years of age. The cumulative probability of the combined end point was significantly higher in boys (5%) than in girls (1%; P <0.001). Risk factors for cardiac arrest or sudden cardiac death during childhood included corrected QT interval [QTc] duration >500 ms (hazard ratio [HR]; 2.72; 95% confidence interval [CI], 1.50 to 4.92; P =0.001) and prior syncope (recent syncope [<2 years]: HR, 6.16; 95% CI 3.41 to 11.15; P <0.001; remote syncope [≥2 years]: HR, 2.67; 95% CI, 1.22 to 5.85; P =0.01) in boys, whereas prior syncope was the only significant risk factor among girls (recent syncope: HR, 27.82; 95% CI, 9.72 to 79.60; P <0.001; remote syncope: HR, 12.04; 95% CI, 3.79 to 38.26; P <0.001). β-Blocker therapy was associated with a significant 53% reduction in the risk of cardiac arrest or sudden cardiac death ( P =0.01). Conclusions— LQTS boys experience a significantly higher rate of fatal or near-fatal cardiac events than girls during childhood. A QTc duration >500 ms and a history of prior syncope identify risk in boys, whereas prior syncope is the only significant risk factor among girls. β-Blocker therapy is associated with a significant reduction in the risk of life-threatening cardiac events during childhood.
Inherited Arrhythmias
Lehnart, Stephan E. , Ackerman, Michael J. , Benson, D. Woodrow , Clancy, Colleen E. , Donahue, J. Kevin , Grant, Augustus O., Groft, Stephen C. , January, Craig T., Lathrop, David A. , Lederer, W. Jonathan , Makielski, Jonathan C., Mohler, Peter J. , Moss, Arthur J. , Nerbonne, Jeanne M. , Olson, Timothy M. , Przywara, Dennis A., Towbin, Jeffrey A. , Wang, Lan-Hsiang, Marks, Andrew R. , Brugada, Ramón , George, Alfred L. , Olson, Timothy M

Mayo Clinic

Circulation | November 12, 2007 | Volume: 116 | Issue: 20 | Pages: 2325-2345

10.1161/circulationaha.107.711689 | PMID 17998470 Get It

The National Heart, Lung, and Blood Institute and Office of Rare Diseases at the National Institutes of Health organized a workshop (September 14 to 15, 2006, in Bethesda, Md) to advise on new research directions needed for improved identification and treatment of rare inherited arrhythmias. These included the following: (1) Na + channelopathies; (2) arrhythmias due to K + channel mutations; and (3) arrhythmias due to other inherited arrhythmogenic mechanisms. Another major goal was to provide recommendations to support, enable, or facilitate research to improve future diagnosis and management of inherited arrhythmias. Classifications of electric heart diseases have proved to be exceedingly complex and in many respects contradictory. A new contemporary and rigorous classification of arrhythmogenic cardiomyopathies is proposed. This consensus report provides an important framework and overview to this increasingly heterogeneous group of primary cardiac membrane channel diseases. Of particular note, the present classification scheme recognizes the rapid evolution of molecular biology and novel therapeutic approaches in cardiology, as well as the introduction of many recently described diseases, and is unique in that it incorporates ion channelopathies as a primary cardiomyopathy in consensus with a recent American Heart Association Scientific Statement.
Cognitive Rehabilitation Interventions for Executive Function: Moving from Bench to Bedside in Patients with Traumatic Brain Injury
Cicerone, Keith D. , Levin, Harvey S. , Malec, James F. , Stuss, Donald T. , Whyte, John

Mayo Clinic

Journal of Cognitive Neuroscience | July 13, 2006 | Volume: 18 | Issue: 7 | Pages: 1212-1222

10.1162/jocn.2006.18.7.1212 | PMID 16839293 Get It

Abstract Executive function mediated by prefrontally driven distributed networks is frequently impaired by traumatic brain injury (TBI) as a result of diffuse axonal injury and focal lesions. In addition to executive cognitive functions such as planning and working memory, the effects of TBI impact social cognition and motivation processes. To encourage application of cognitive neuroscience methods to studying recovery from TBI, associated reorganization of function, and development of interventions, this article reviews the pathophysiology of TBI, critiques currently employed methods of assessing executive function, and evaluates promising interventions that reflect advances in cognitive neuroscience. Brain imaging to identify neural mechanisms mediating executive dysfunction and response to interventions following TBI is also discussed.
The NHLBI Lymphangioleiomyomatosis Registry
Ryu, Jay H. , Moss, Joel , Beck, Gerald J. , Lee, Jar-Chi, Brown, Kevin K. , Chapman, Jeffrey T., Finlay, Geraldine A., Olson, Eric J. , Ruoss, Stephen J. , Maurer, J.R., Raffin, Thomas A., Peavy, Hannah, Taveira‐DaSilva, Angelo M., McCormack, Francis X. , Avila, Nilo A., DeCastro, Rosamma, Jacobs, Susan S. , Stylianou, Mario, Fanburg, Barry L., Lee, Jar-Chi, McCarthy, Kevin , McCormack, Francis X , Ryu, Jay H

Mayo Clinic

American Journal of Respiratory and Critical Care Medicine | October 6, 2005 | Volume: 173 | Issue: 1 | Pages: 105-111

10.1164/rccm.200409-1298oc | PMID 16210669 Get It

Abstract Rationale Pulmonary lymphangioleiomyomatosis is a progressive cystic lung disease that is associated with infiltration of atypical smooth muscle–like cells. Previous descriptions of clinical characteristics of subjects with lymphangioleiomyomatosis have been based on a limited number of patients. Objectives To describe the clinical characteristics of subjects with pulmonary lymphangioleiomyomatosis, both sporadic and tuberous sclerosis–related forms. Methods Over a 3-yr period, from 1998 to 2001, 243 subjects with pulmonary lymphangioleiomyomatosis were enrolled into a national registry; 13 subjects who had already undergone lung transplantation were excluded for the purposes of this report. Measurements and Main Results All 230 subjects were women, aged 18 to 76 yr (mean ± SE, 44.5 ± 0.65 yr). The average age at onset of symptoms was 38.9 ± 0.73 yr and at diagnosis was 41.0 ± 0.65 yr. Tuberous sclerosis complex was present in 14.8% of subjects. Pulmonary manifestations, most commonly spontaneous pneumothorax, were the primary events leading to the diagnosis in 86.5% of cases. Nearly 55% of the subjects were being treated with a progesterone derivative. An obstructive pattern on pulmonary function testing was observed in 57.3% of the subjects, whereas 33.9% had normal spirometric results. Women with tuberous sclerosis–related lymphangioleiomyomatosis were younger and had less impaired lung function compared with those with the sporadic form. Conclusions The age range of women afflicted with pulmonary lymphangioleiomyomatosis is broader than previously appreciated and the degree of pulmonary function can be quite variable, with one-third of subjects having normal spirometry at enrollment into this registry.
Hepatic B‐cell non‐Hodgkin's lymphoma of MALT type in the liver explant of a patient with chronic hepatitis C infection
Orrego, Mauricio , Guo, Linsheng, Reeder, Craig B. , Petris, Giovanni De , Balan, Vijayan , Douglas, David D., Byrne, Thomas , Harrison, Edwyn M, Mulligan, David C. , Rodriguez‐Luna, Hector, Moss, Adyr A. , Reddy, Kunam , Rakela, Jorge , Vargas, Hugo E. , Vargas, Hugo E

Mayo Clinic

Liver Transplantation | June 22, 2005 | Volume: 11 | Issue: 7 | Pages: 796-799

10.1002/lt.20384 | PMID 15973702 Get It

Rapid Assembly of Amyloid-β Peptide at a Liquid/Liquid Interface Produces Unstable β-Sheet Fibers
Nichols, Michael R. , Moss, Melissa A. , Reed, Dana Kim , Hoh, Jan H. , Rosenberry, Terrone L.

Mayo Clinic

Biochemistry | January 4, 2005 | Volume: 44 | Issue: 1 | Pages: 165-173

10.1021/bi048846t | PMID 15628857 Get It